Skip to main content

CAPTRUST FINANCIAL ADVISORS

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1512024 RALEIGH, NC

Position in TAK

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,937,809
+$1,086,123 QoQ
Shares Held
158,629
+33.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 1.8685108019340726.ToString("F0")% Shared 0.ToString("F0")% None 98.13148919806592.ToString("F0")%

Common Shares in TAK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CAPTRUST FINANCIAL ADVISORS holds $56,556,259 across 24 Drug Manufacturers - Specialty & Generic names. TAK ranks #5 (5.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 TAK
Takeda Pharmaceutical Co Ltd
This page
158,629 $2,937,809

All Filings in TAK

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,937,809 158,629
2025-12-31 $1,851,686 118,774
2025-09-30 $601,762 41,104
2025-06-30 $594,282 38,440
2025-03-31 $539,052 36,251
2024-12-31 $230,826 17,434
2024-09-30 $343,213 24,136
2024-06-30 $337,759 26,102
2024-03-31 $529,236 38,102
2023-12-31 $803,786 56,327
2023-09-30 $919,119 59,413
2023-06-30 $511,580 32,564
2023-03-31 $517,884 31,425
2022-12-31 $569,883 36,531
2022-09-30 $206,975 15,958
2022-06-30 $174,166 12,405
2022-03-31 $120,774 8,434
2021-12-31 $212,641 15,601
2021-09-30 $126,453 7,720
2021-06-30 $148,171 8,804
2021-03-31 $148,033 8,107
2020-12-31 $111,420 6,122
2020-09-30 $74,999 4,204
2020-06-30 $54,722 3,052